First Circ. Revives Boston Scientific Securities Suit
A case filed by Boston Scientific Corp. shareholders over the biotech company's alleged failure to disclose information about the recall of one of its stents will stay alive, now that an...To view the full article, register now.
Already a subscriber? Click here to view full article